We previously demonstrated that BTZ loaded into a chitosan nanoparticle and decorated with anti-CD38 antibodies improved the accumulation of BTZ in MM cells, which overexpress CD38, and reduced the toxicity of BTZ in normal tissue14. The gene discussed is CASC3; the disease is Miyoshi myopathy.